Stryker schedules October 29 results. Stryker stock falls 2.15 percent
Published on 10/27/2026 at 17:12 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWSAnalyst target and trading position
- Stryker will discuss third-quarter 2026 results on October 29, 2026, at 4:30 p.m. ET.
- BTIG lowered its target to USD 316.00 from USD 358.00 on October 12, 2026.
- Stryker stock costs EUR 268.90 at Lang & Schwarz on October 27, 2026 at 5:06 p.m. CET, down 2.15 percent versus the Xetra close.
Stryker Corp. (ISIN US8636671013) will discuss its third-quarter 2026 financial results on October 29, 2026, at 4:30 p.m. ET, according to StockTitan. Stryker was trading at EUR 268.90 at Lang & Schwarz on October 27, 2026 at 5:06 p.m. CET, down 2.15 percent versus the Xetra close of October 26, 2026 at EUR 274.80.
BTIG lowers its target
Markets Insider reported on October 12, 2026 that BTIG lowered its Stryker target to USD 316.00 from USD 358.00 while keeping a Buy rating. Against the primary-exchange quote of USD 299.57 at 12:11 p.m. ET on October 27, 2026, the new target stands 5.48 percent above the price.
Stock remains below its yearly high
On the NYSE, Stryker traded at USD 299.57 on October 27, 2026 at 12:11 p.m. ET. The USD 267.00 to USD 389.33 52-week range places the stock 12.20 percent above its low and 23.06 percent below its high. The market capitalization was USD 114.9 billion and the price-to-earnings ratio was 31.02 on the same date.
Revenue sets the earnings backdrop
Stryker reported revenue of USD 6.59 billion for the second quarter of 2026, up 9.40 percent from the prior-year quarter, according to MarketBeat. The company enters the October 29 report with annual 2026 adjusted earnings-per-share guidance of USD 14.95 to USD 15.10, also stated in the October 25, 2026 report.
The next dated test is the third-quarter release on October 29, 2026, followed by the webcast at 4:30 p.m. ET. The scheduled release gives investors a defined checkpoint for the revenue trend and the gap between BTIG's USD 316.00 target and the USD 299.57 NYSE quote.
Price gives investors a clear checkpoint
Stryker's euro quotation is 2.15 percent below the Xetra close of October 26, 2026, while the primary-exchange quote remains above its 52-week low. The October 29 results will provide the next dated operating measure.
The further course of trading is shown by the continuously updated real-time quote of Stryker stock.
Stryker stock facts
- Company: Stryker Corporation
- ISIN: US8636671013
- Ticker: SYK
- Primary exchange: NYSE
- Price Lang & Schwarz (as of October 27, 2026, 5:06 p.m. CET): EUR 268.90
- Change versus Xetra close: minus 2.15 percent
- Xetra close (October 26, 2026): EUR 274.80
- Market capitalization: USD 114.9 billion (as of October 27, 2026)
- 52-week range: USD 267.00-389.33 (as of October 27, 2026)
- Sector / Industry: Healthcare / Medical Devices
- Next earnings date: October 29, 2026
Market context: Market report S&P 500.
